erythrocyte Membrane Protein Band 4.2 (EPB42) Peptid
EPB42
Reaktivität: Human
Wirt: Synthetic
BP, WB
-
- Target Alle EPB42 Produkte
- EPB42 (erythrocyte Membrane Protein Band 4.2 (EPB42))
- Spezies
- Human
-
Quelle
- Synthetic
- Applikation
- Blocking Peptide (BP), Western Blotting (WB)
- Produktmerkmale
- This is a synthetic peptide designed for use in combination with anti-EPB42 antibody (Catalog #: ARP33799_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Aufreinigung
- Purified
-
-
- Applikationshinweise
- Each Investigator should determine their own optimal working dilution for specific applications.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Konzentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handhabung
- Avoid repeated freeze-thaw cycles.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- EPB42 (erythrocyte Membrane Protein Band 4.2 (EPB42))
- Synonyme
- PA Peptide, SPH5 Peptide, Epb4.2 Peptide, Epb42 Peptide, erythrocyte membrane protein band 4.2 Peptide, EPB42 Peptide, Epb42 Peptide
- Hintergrund
-
Erythrocyte membrane protein band 4.2 is an ATP-binding protein which may regulate the association of protein 3 with ankyrin. It probably has a role in erythrocyte shape and mechanical property regulation. Mutations in the EPB42 gene are associated with recessive spherocytic elliptocytosis and recessively transmitted hereditary hemolytic anemia.
Alias Symbols: PA, SPH5
Protein Interaction Partner: SPINK7,ANK1,CD47,CNO,EPB41,EPB49,KRAS,SLC4A2,SPINK7,SPTAN1,STX12,ANK2,KRAS,SLC4A1,SPINK7,SPTAN1
Protein Size: 721 - Molekulargewicht
- 80 kDa
- Gen-ID
- 2038
- NCBI Accession
- NM_000119, NP_000110
-
Sie sind hier:
